WASHINGTON -- A marketing campaign for a GlaxoSmithKline prostate drug has drawn complaints from federal regulators, who said the space-themed advertisement is misleading. The British drugmaker's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback